Telesis Bio, Inc. (TBIO)

NASDAQ: TBIO · IEX Real-Time Price · USD
0.440
+0.010 (2.30%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Total Valuation

Telesis Bio has a market cap or net worth of $13.19 million. The enterprise value is $21.48 million.

Market Cap 13.19M
Enterprise Value 21.48M

Important Dates

The last earnings date was Thursday, March 28, 2024, after market close.

Earnings Date Mar 28, 2024
Ex-Dividend Date n/a

Share Statistics

Telesis Bio has 29.98 million shares outstanding. The number of shares has increased by 1.45% in one year.

Shares Outstanding 29.98M
Shares Change (YoY) +1.45%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 37.70%
Owned by Institutions (%) 38.38%
Float 9.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.44
Forward PS 0.40
PB Ratio 0.74
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 2.81.

Current Ratio 2.07
Quick Ratio 1.85
Debt / Equity 2.81
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -23.96

Financial Efficiency

Return on equity (ROE) is -120.70% and return on invested capital (ROIC) is -54.67%.

Return on Equity (ROE) -120.70%
Return on Assets (ROA) -39.90%
Return on Capital (ROIC) -54.67%
Revenue Per Employee $134,534
Profits Per Employee -$174,395
Employee Count 223
Asset Turnover 0.31
Inventory Turnover 3.51

Taxes

In the past 12 months, Telesis Bio has paid $27,000 in taxes.

Income Tax 27,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.06% in the last 52 weeks. The beta is 1.98, so Telesis Bio's price volatility has been higher than the market average.

Beta (1Y) 1.98
52-Week Price Change -84.06%
50-Day Moving Average 0.43
200-Day Moving Average 0.86
Relative Strength Index (RSI) 44.97
Average Volume (30 Days) 788,004

Short Selling Information

The latest short interest is 226,264, so 0.75% of the outstanding shares have been sold short.

Short Interest 226,264
Short Previous Month 341,819
Short % of Shares Out 0.75%
Short % of Float 2.48%
Short Ratio (days to cover) 0.11

Income Statement

In the last 12 months, Telesis Bio had revenue of $30.00 million and -$38.89 million in losses. Loss per share was -$1.30.

Revenue 30.00M
Gross Profit 18.65M
Operating Income -37.00M
Pretax Income -38.14M
Net Income -38.89M
EBITDA -32.79M
EBIT -36.61M
Loss Per Share -$1.30
Full Income Statement

Balance Sheet

The company has $41.63 million in cash and $49.92 million in debt, giving a net cash position of -$8.29 million or -$0.28 per share.

Cash & Cash Equivalents 41.63M
Total Debt 49.92M
Net Cash -8.29M
Net Cash Per Share -$0.28
Equity / Book Value 17.77M
Book Value Per Share 0.59
Working Capital 27.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.99 million and capital expenditures -$2.48 million, giving a free cash flow of -$35.47 million.

Operating Cash Flow -32.99M
Capital Expenditures -2.48M
Free Cash Flow -35.47M
FCF Per Share -$1.18
Full Cash Flow Statement

Margins

Gross margin is 62.15%, with operating and profit margins of -123.34% and -129.63%.

Gross Margin 62.15%
Operating Margin -123.34%
Pretax Margin -127.14%
Profit Margin -129.63%
EBITDA Margin -109.29%
EBIT Margin -122.04%
FCF Margin -118.23%

Dividends & Yields

Telesis Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.45%
Shareholder Yield -1.45%
Earnings Yield -294.78%
FCF Yield -268.85%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Telesis Bio has an Altman Z-Score of -2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.33
Piotroski F-Score 3